๐ฌIn plain words
What the trial is, and whether it could suit you
This randomized controlled trial aims to evaluate the effectiveness of an Agentic AI-based personalized dietary management algorithm among adults undergoing health screening. Participants will be assigned to a control group, a static goal AI intervention group, or an adaptive goal AI intervention group and followed for 12 weeks.
Sign in to get the eligibility rules as simple questions to take to your doctor.
๐ Eligibility rules (as published)
Inclusion Criteria:
* Adults aged 20 years or older
* Individuals from the general population who underwent a health examination at the Seoul National University Hospital Healthcare System Gangnam Center
* Individuals who are capable of independently using a smartphone and operating study-related applications or text messaging functions
* Individuals without conditions that significantly interfere with standard dietary management, as specified in the exclusion criteria \[Section 9.2 Exclusion Criteria\]
Exclusion Criteria:
* Individuals unable to use a smartphone or study-related digital program/application, including those without a smartphone or unable to operate text messaging or application-based functions.
* End-stage renal disease or patients currently receiving dialysis
* Active cancer or currently undergoing chemotherapy or radiotherapy
* Severe heart failure, liver cirrhosis, or hepatic insufficiency accompanied by varices, bleeding, ascites, hepatic encephalopathy, or jaundice
* Malabsorption disorders such as Crohn's disease or short bowel syndrome
* Poorly controlled hyperthyroidism or hypothyroidism
* Diagnosed eating disorders or severe psychiatric disorders
* Pregnant or breastfeeding women, or women who may become pregnant during study participation.
* Individuals with recent major weight-related interventions or extreme body weight changes within the past 3 months, including:Bariatric surgery such as gastrectomy or gastric bypass surgery Newly initiated anti-obesity pharmacotherapy (e.g., semaglutide/Wegovy, tirzepatide/Mounjaro)
* Individuals considered by the investigator to have poor compliance potential or otherwise deemed unsuitable for participation in the clinical study.